↓ Skip to main content

MMP-9 as a Candidate Marker of Response to BRAF Inhibitors in Melanoma Patients With BRAFV600E Mutation Detected in Circulating-Free DNA

Overview of attention for article published in Frontiers in Pharmacology, August 2018
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
77 Dimensions

Readers on

mendeley
52 Mendeley